Article Figures & Data
Tables
HC (n = 73) RRMS (n = 162) SPMS (n = 66) Age, median (IQR) 44 (17) 44 (16) 54.5 (9) Sex % Male 45.2 22.8 19.7 Male/female 33/40 37/125 13/53 EDSS, median (IQR) [# missing] 2 (1.5) [8] 6 (2) [2] Disease duration, years; median (IQR) 9 (11) 19.5 (18) -
Note:—Of the 228 patients with MS, 204 were on disease-modifying therapy. These included 68 patients on interferon beta-1a I.M., 23 on interferon beta 1a S.C., 1 on interferon beta 1b, 46 on glatiramer acetate, 50 on natalizumab, 3 on intravenous immunoglobulin, 4 on mycophenolate mofetil, 2 on azathioprine, 2 on combination therapy, and 1 on mitoxantrone; drug data for 4 patients were not recorded. IQR indicates interquartile range.
-